Health Care: Drugs

Novartis AG (NVS: NYSE)

$98.95 n/a | n/a%
03/05/15 - 04:02 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 10.73B 9.29B 9.62B 9.24B
Operating Gains/Losses 0.00 0.00 0.00 404.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -367.00M -411.00M 0.00 -732.00M
(Increase) Decrease in Inventories -506.00M -653.00M 0.00 45.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 142.00M 502.00M 0.00 195.00M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 106.00M -177.00M -140.00M 379.00M
Other Non-Cash Items 3.80B 4.62B 6.74B 7.21B
Net Cash From Continuing Operations 13.90B 13.17B 14.19B 14.31B
Net Cash From Discontinued Operations -1.00M 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 13.90B 13.17B 14.19B 14.31B
Sale of Property, Plant & Equipment 306.00M 214.00M 255.00M 704.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 516.00M 3.34B
Purchases of Property, Plant & Equipment -3.40B -3.57B -3.07B -2.39B
Acquisitions 1.04B -94.00M -1.74B -581.00M
Purchases of Short-Term Investments 0.00 0.00 -1.64B -1.75B
Other Cash from Investing Activities -58.00M -22.00M -39.00M 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 881.00M -3.35B -5.68B -792.00M
Issuance of Debt 6.02B 93.00M 1.98B 281.00M
Cash Used for Financing Activities
Issuance of Capital Stock 2.40B 1.69B 414.00M 163.00M
Repayment of Long-Term Debt -2.60B -2.02B -2.44B -3.08B
Repurchase of Capital Stock -6.92B -2.93B -505.00M -3.63B
Payment of Cash Dividends -6.95B -6.20B -6.12B -5.57B
Other Financing Charges, Net -107.00M 600.00M -6.00M -3.19B
Net Cash From Financing Activities -8.15B -8.77B -6.68B -15.02B
Effect of Exchange Rate Changes -295.00M 82.00M -1.00M -103.00M
Net Change in Cash & Cash Equivalents 6.34B 1.14B 1.84B -1.61B

Portfolios with NVS

Latest NVS Headlines from TheStreet

More Financial News for NVS

Press Releases for NVS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter